Abstract: The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.

Abstract: A display device includes: a substrate; a first pixel electrode and a second pixel electrode on the substrate; a dummy pixel electrode between the first pixel electrode and the second pixel electrode, and to receive a dummy voltage; an emissive layer on the first pixel electrode, the second pixel electrode, and the dummy pixel electrode; and a common electrode on the emissive layer. The first pixel electrode is to receive a pixel voltage different from the dummy voltage.

Abstract: A cooking apparatus has a cooking chamber, a microwave unit to radiate microwaves to the cooking chamber, a convection unit to supply hot air to the cooking chamber, a grill unit to supply radiant heat to the cooking chamber, an input unit to receive a cooking command and a control unit to perform a cooking corresponding to the received cooking command by performing one of a first heating stage and a second heating stage, and after performing the one of the first heating stage and the second heating stage, performing the other one of the first heating stage and the second heating stage. In the first heating stage, the control unit operates the microwave unit and at least one of the convection unit and the grill unit, and in the second heating stage, the control unit operates the grill unit and the convection unit while not operating the microwave unit.

Abstract: A display device includes: a first pixel and a second pixel, including: a first transistor comprising a first active region, a first drain electrode, and a first source electrode respectively on one side and another side of the first active region, and a first gate electrode overlapping the first active region, a first capacitor electrode connected to the first gate electrode and overlapping the first source electrode, and a light emitting element connected to the first transistor, wherein a first end of the first source electrode of the first pixel, and a second end of the first source electrode of the second pixel face each other, a third end of the first capacitor electrode of the first pixel, and a fourth end of the first capacitor electrode of the second pixel face each other, and the first end is between the third end and the fourth end.

Abstract: A display device includes a substrate, a corrosion prevention layer on the substrate and including an inorganic material, a first conductive layer on the corrosion prevention layer and including aluminum or an aluminum alloy, a first insulating film on the first conductive layer, a semiconductor layer on the first insulating film and including a channel region of a transistor, a second insulating film on the semiconductor layer, and a second conductive layer on the second insulating film and including a barrier layer, which includes titanium, and a main conductive layer, which includes aluminum or an aluminum alloy, wherein the semiconductor layer includes an oxide semiconductor, and the barrier layer is between the semiconductor layer and the main conductive layer and overlaps the channel region of the transistor.

Abstract: The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.

Abstract: A display device according to an embodiment includes: a first metal layer disposed on a substrate; a first insulating layer disposed on the first metal layer; a first transistor disposed on the first insulating layer and including a semiconductor layer; and a light-emitting device electrically connected to the first transistor, wherein the first metal layer includes a first portion with a first thickness and a second portion with a second thickness, the second thickness is greater than the first thickness, and the semiconductor layer is electrically connected to the first metal layer.

Abstract: A cooking apparatus has a cooking chamber, a microwave unit to radiate microwaves to the cooking chamber, a convection unit to supply hot air to the cooking chamber, a grill unit to supply radiant heat to the cooking chamber, an input unit to receive a cooking command and a control unit to perform a cooking corresponding to the received cooking command by performing one of a first heating stage and a second heating stage, and after performing the one of the first heating stage and the second heating stage, performing the other one of the first heating stage and the second heating stage. In the first heating stage, the control unit operates the microwave unit and at least one of the convection unit and the grill unit, and in the second heating stage, the control unit operates the grill unit and the convection unit while not operating the microwave unit.

Abstract: Disclosed is a biological measurement device. The biological measurement device includes a first plate including a first transmission window; an electrode structure disposed on the first plate and spaced apart from the first window; a chamber plate disposed over the electrode structure and the first plate, the chamber plate including for exposing a portion of the electrode structure and the first transmission window; a second plate disposed over the chamber plate, the second plate including a second transmission window facing the first transmission window; a light emitting unit positioned either over the second transmission window and emitting light toward the second transmission window; and a light receiving unit disposed under the first transmission window and being configured to receive the light which the light emitting unit supplies to pass through the blood sample.

Abstract: A composition comprising an extract of combined herbs Acanthopanax koreanum Nakai and Crinum asiaticum var. japonicum showing treatment activity of a hair baldness disorder and stimulating activity of hair growth. The combined extract showed potent hair-growth promoting activity and a synergistic effect compared to each herb, i.e. the sole treatment of Acanthopanax koreanum Nakai or Crinum asiaticum var. japonicum, through animal model experiments, such as, the growth rate test using C57BL/6 mouse, to confirm the effect of the combined extract, i.e. combined treatment of Acanthopanax koreanum Nakai and Crinum asiaticum var. japonicum. Therefore the extract can be useful in treating a hair baldness disorder.

Abstract: The present invention relates to an agent apparatus and method for sharing anonymous identifier-based security information among security management domains. A plurality of security information sharing agent apparatuses respectively located in a plurality of security management domains and configured to collect security information and transmit collected security information to outside of the security management domains.

Abstract: The present invention provides a new group of protein kinase inhibitors, pyrropyrimidine and pyrazolopyrimidine derivatives, and pharmaceutically acceptable salts and prodrugs thereof that are useful for treating cell proliferative disease and disorder such as cancer, autoimmune diseases, infection, cardiovascular disease and neurodegenerative disease and disorder. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor. The invention also provides useful intermediates generated during the syntheses of the pyrropyrimidine and pyrazolopyrimidine derivatives.

Abstract: An apparatus for quantifying network threat situations includes a traffic analyzing unit to analyze packet patterns of traffics occurring on a target network being monitored to extract one or more suspicious domains. An IP monitoring unit gives security levels among a plurality of security levels to the suspicious domains according to the number of access IPs accessing the suspicious domains. An activity index computing unit computes activity indices for the suspicious domains from activity indices according to the access times to the suspicious domains of the access IPs. An attack amount anticipation unit analogizes an expected amount of attacks for each suspicious domain according to an expected amount of attacks for each zombie computer, the security level and the activity index of the suspicious domain.

Abstract: The present invention relates to an agent apparatus and method for sharing anonymous identifier-based security information among security management domains. A plurality of security information sharing agent apparatuses respectively located in a plurality of security management domains and configured to collect security information and transmit collected security information to outside of the security management domains.

Abstract: The present invention provides a new group of protein kinase inhibitors, pyrido[4,3,-d]pyrimidin-5-one derivatives, and pharmaceutically acceptable salts thereof that are useful for intreating cell proliferative disease and disorder such as cancer, autoimmune diseases, infection, cardiovascular disease and neurodegenerative disease and disorder. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor. The invention also provides useful intermediates generated during the syntheses of the pyrido[4,3,-d]pyrimidin-5-one derivatives.

Abstract: Disclosed are a system for sharing information between heterogeneous service providers, including: a first service provider configured to generate first situation information based on an abnormal situation of a system; a second service provider configured to receive the first situation information from the first service provider, generate second situation information corresponding to the received first situation information; and the TTP configured to receive the first situation information from the first service provider, receive the second situation information from the second service provider, generate correspondence information based on the received information, and share the generated correspondence information.

Abstract: Disclosed are a cyber threat prior prediction apparatus, including a DNS based C&C server detecting unit configured to analyze DNS traffic to extract a domain address which is suspected as a C&C server; a network based abnormality detecting unit configured to analyze the network traffic to detect IP addresses of zombie PCs which access the C&C server and information of the zombie PCs; and a cyber threat predicting unit configured to predict a cyber threat situation based on the information of the zombie PCs.

Abstract: An apparatus for quantitatively evaluating security policy includes: a security policy analyzing unit for analyzing a security policy of a network; an evaluation criterion defining unit for defining an evaluation criterion for categorizing security features and evaluating each of the security features; an evaluation result calculating unit for calculating an evaluation result of each of security components based on the evaluation criterion; an indicator calculating unit for grouping the security components according to a security function and calculating an indicator by considering a security function of each group; and a quantitative evaluating unit for evaluating a security policy of the each group by using the indicator.

Abstract: The present invention provides a new group of protein kinase inhibitors, pyrropyrimidine and pyrazolopyrimidine derivatives, and pharmaceutically acceptable salts and prodrugs thereof that are useful for treating cell proliferative disease and disorder such as cancer, autoimmune diseases, infection, cardiovascular disease and neurodegenerative disease and disorder. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor. The invention also provides useful intermediates generated during the syntheses of the pyrropyrimidine and pyrazolopyrimidine derivatives.

Abstract: The present invention provides a new group of protein kinase inhibitors, pyrido[4,3,-d]pyrimidin-5-one derivatives, and pharmaceutically acceptable salts thereof that are useful for intreating cell proliferative disease and disorder such as cancer, autoimmune diseases, infection, cardiovascular disease and neurodegenerative disease and disorder. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor. The invention also provides useful intermediates generated during the syntheses of the pyrido[4,3,-d]pyrimidin-5-one derivatives.